Open Access Repository

New psychoactive substances: challenges for drug surveillance, control, and public health responses

Peacock, A, Bruno, R ORCID: 0000-0001-6673-833X, Gisev, N, Degenhardt, L, Hall, W, Sedefov, R, White, J, Thomas, KV, Farrell, M and Griffiths, P 2019 , 'New psychoactive substances: challenges for drug surveillance, control, and public health responses' , The Lancet, vol. 394, no. 10209 , pp. 1668-1684 , doi: 10.1016/S0140-6736(19)32231-7.

Full text not available from this repository.

Abstract

The rapid emergence since the mid-2000s of a large and diverse range of substances originally designed as legal alternativesto more established illicit drugs (pragmatically clustered and termed new psychoactive substances; [NPS]) has challengedtraditional approaches to drug monitoring, surveillance, control, and public health responses. In this section of the Series,we describe the emergence of NPS and consider opportunities for strengthening the detection, identification, andresponses to future substances of concern. First, we explore the definitional complexity of the term NPS. Second, wedescribe the origins and drivers surrounding NPS, including motivations for use. Third, we summarise evidence on NPSavailability, use, and associated harms. Finally, we use NPS as a case example to explore challenges and opportunities forfuture drug monitoring, surveillance, control, and public health responses. We posit that the current means of respondingto emerging substances might no longer be fit for purpose in a world in which different substances can be rapidlyintroduced, and where people who use drugs can change preferences on the basis of market availability

Item Type: Article
Authors/Creators:Peacock, A and Bruno, R and Gisev, N and Degenhardt, L and Hall, W and Sedefov, R and White, J and Thomas, KV and Farrell, M and Griffiths, P
Keywords: novel psychoactive substances
Journal or Publication Title: The Lancet
Publisher: Lancet Ltd
ISSN: 0140-6736
DOI / ID Number: 10.1016/S0140-6736(19)32231-7
Copyright Information:

Copyright 2019 Elsevier Ltd.

Related URLs:
Item Statistics: View statistics for this item

Actions (login required)

Item Control Page Item Control Page
TOP